等待开盘 11-17 09:30:00 美东时间
-0.018
-8.53%
今日重点评级关注:花旗:维持Faeth Therapeutics"买入"评级,目标价从55美元升至60美元;HC Wainwright & Co.:维持Ocular Therapeutix"买入"评级,目标价从25美元升至28美元
11-11 10:50
Needham analyst Ryan MacDonald maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $3 to $1.
11-10 21:25
DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced that the Board has begun a comprehensive search to identify the next CEO, as Mr. Bienstock’s employment contract expires on December 31, 2...
11-10 06:00
DocGo (NASDAQ:DCGO) lowers FY2026 sales outlook from $305.000 million-$310.000 million to $300.000 million vs $306.500 million estimate.
11-10 05:41
DocGo ( ($DCGO) ) has shared an announcement. On October 1, 2026, DocGo and sub...
10-05 18:58
今日重点评级关注:Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从14.5美元升至15美元;摩根大通:维持Annexon"超配"评级,目标价从14美元升至15美元
10-01 19:18
Needham analyst Ryan MacDonald reiterates DocGo (NASDAQ:DCGO) with a Buy and maintains $3 price target.
09-30 18:02
今日重点评级关注:HC Wainwright & Co.:维持Tango Therapeutics"买入"评级,目标价从66美元升至68美元;康托·菲茨杰拉德:维持Duos Technologies Group"超配"评级,目标价从26美元升至27美元
08-19 08:37
Needham analyst Ryan MacDonald reiterates DocGo (NASDAQ:DCGO) with a Buy and maintains $3 price target.
08-18 18:13
DocGo (NASDAQ:DCGO) narrows FY2026 sales outlook from $300.000 million-$315.000 million to $305.000 million-$310.000 million vs $306.281 million estimate.
08-18 04:23